Identification of amidoheteroaryls as potent inhibitors of mutant (V600E) B-Raf kinase with in vivo activity

被引：10

作者：

Lyne, Paul D. ^{[1
]}

Aquila, Brian ^{[1
]}

Cook, Donald J. ^{[1
]}

Dakin, Les A. ^{[1
]}

Ezhuthachan, Jay ^{[1
]}

Ioannidis, Stephanos ^{[1
]}

Pontz, Timothy ^{[1
]}

Su, Mei ^{[1
]}

Ye, Qing ^{[1
]}

Zheng, Xiaolan ^{[1
]}

Block, Michael H. ^{[1
]}

Cowen, Scott ^{[1
]}

Deegan, Tracy L. ^{[1
]}

Lee, John W. ^{[1
]}

Scott, David A. ^{[1
]}

Custeau, Dominique ^{[1
]}

Drew, Lisa ^{[1
]}

Poondru, Srinivasu ^{[1
]}

Shen, Minhui ^{[1
]}

Wu, Allan ^{[1
]}

机构：

[1] AstraZeneca R&D Boston, Canc Res, Waltham, MA 02451 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2009年 / 19卷 / 03期

关键词：

B-Raf; V600E; Amidoheteroaryl; P38 MAP KINASE; ACTIVATION; MUTATIONS; CANCER; PATHWAY;

D O I：

10.1016/j.bmcl.2008.10.053

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of amidoheteroaryl compounds were designed and synthesized as inhibitors of B-Raf kinase. Several compounds from the series show excellent potency in biochemical, phenotypic and mode of action cellular assays. Potent examples from the series have also demonstrated good plasma exposure following an oral dose in rodents and activity against the Ras-Raf pathway in tumor bearing mice. (C) 2008 Elsevier Ltd. All rights reserved.

引用

页码：1026 / 1029

页数：4

共 50 条

[1] Discovery and optimization of a novel series of potent inhibitors of mutant (V600E) B-Raf kinase
Vasbinder, Melissa
Aquila, Brian
Cook, Donald
Drew, Lisa
Fauber, Benjamin
Grondine, Michael
Hennessy, Edward
Lyne, Paul
Omer, Charles
Palakurthi, Sangeetha
Sha, Li
Shen, Minhui
Wang, Haixia
Ye, Minwei
CANCER RESEARCH, 2009, 69
[2] The inability of Spry2 to inhibit B-Raf V600E activity is required for induction of resistance to B-Raf inhibitor in B-Raf V600E cells
Han, Byeal-I
Ahn, Jun-Ho
Jang, Gun-Hee
Kim, Na-Yeon
Lee, Michael
FASEB JOURNAL, 2015, 29
[3] Understanding the effects of RAF inhibitors on RAF signaling in B-RAF V600E mutant versus wild type tumors
Yen, Ivana
Song, Kyung
Stokoe, David
Brandhuber, Barbara
Gloor, Susan
Aliagas, Ignacio
Anderson, Daniel
Morales, Tony
Vigers, Guy
Ludlam, Mary
Alvarado, Ryan
Liu, Bonnie
Sideris, Steve
Ramaswamy, Sreema
Heise, Christopher
Belvin, Marcia
Friedman, Lou
Hatzivassiliou, Georgia
Malek, Shiva
MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
[4] Repositioning organohalogen drugs: a case study for identification of potent B-Raf V600E inhibitors via docking and bioassay
Li, Yisu
Guo, Binbin
Xu, Zhijian
Li, Bo
Cai, Tingting
Zhang, Xinben
Yu, Yuqi
Wang, Heyao
Shi, Jiye
Zhu, Weiliang
SCIENTIFIC REPORTS, 2016, 6
[5] Repositioning organohalogen drugs: a case study for identification of potent B-Raf V600E inhibitors via docking and bioassay
Yisu Li
Binbin Guo
Zhijian Xu
Bo Li
Tingting Cai
Xinben Zhang
Yuqi Yu
Heyao Wang
Jiye Shi
Weiliang Zhu
Scientific Reports, 6
[6] Helix-Coil Transition Signatures B-Raf V600E Mutation and Virtual Screening for Inhibitors Directed Against Mutant B-Raf
Bandaru, Srinivas
Sumithnath, Tharaparambil Gangadharan
Sharda, Saphy
Lakhotia, Sanskruti
Sharma, Anudeep
Jain, Amrita
Hussain, Tajamul
Nayarisseri, Anuraj
Singh, Sanjeev Kumar
CURRENT DRUG METABOLISM, 2017, 18 (06) : 527 - 534
[7] Understanding the role of Raf signaling in B-Raf V600E mutant versus wildtype tumors
Hatzivassiliou, G.
Sideris, S.
Yen, I.
Gloor, S.
Callejo, M.
Brandhuber, B.
Liu, B.
Belvin, M.
Malek, S.
EJC SUPPLEMENTS, 2008, 6 (12): : 183 - 184
[8] Novel natural inhibitors targeting B-RAF(V600E) by computational study
Wu, Bo
Zhang, Zhiyun
Dou, Gaojing
Lv, Xiaye
Ge, Junliang
Wang, Hongyu
Xie, Haoqun
Zhu, Dong
BIOENGINEERED, 2021, 12 (01) : 2970 - 2983
[9] The mechanism of activation of monomeric B-Raf V600E
Maloney, Ryan C.
Zhang, Mingzhen
Jang, Hyunbum
Nussinov, Ruth
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2021, 19 : 3349 - 3363
[10] Enhanced B-Raf protein expression is independent of V600E mutant status in thyroid carcinomas
Kondo, Tetsuo
Nakazawa, Tadao
Murata, Shin-ichi
Kurebayashi, Junichi
Ezzat, Shereen
Asa, Sylvia L.
Katoh, Ryohei
HUMAN PATHOLOGY, 2007, 38 (12) : 1810 - 1818

← 1 2 3 4 5 →